Key Objectives

The introduction of electronic traceability will have positive impact on the treatment (real time information about the medication process), on recall procedures (individually focused recalls), on vigilance (faster information flow), on stock management (real time information about the available stocks and consumption), and budgeting (by following and anticipating the consumption).

The key objectives of the proposed system are as follows:

	Real time identification of the location of all CFC* to facilitate rapid, accurate and validated product recall;
	Real time identification of patients treatment history to allow rapid and accurate identification of all patients who have received an "at risk" product;
	The capture of data to validate cold chain storage and delivery of factor concentrates;
	The provision of a system to ensure that the correct product is prescribed and administered to the patient (electronic prescription and administration);
	The provision of a real-time stock management system which would allow: -
	correct dispatch and delivery direct to the patient, hospital and ward;
	optimal stock management with specified re-order levels and stock rotation to minimise wastage due to expiry dates limitations;
	real time stock consumption data with comparison of actual, budgeted and year to date variance presented in stock and cost terms.
	Analysis of patient treatment data to ensure appropriate usage and to flag clinically significant bleeding that requires hospital rather than home treatment.
	Decision support system to analyse the impact on stocks, the cost of prescribing actions and future budget requirements.
	Invoicing system to support the receipt of invoice from the CFC supplier and generation of invoices to customers/hospitals for CFC products
	Back-up processes and procedures, both manual and infrastructure, to manage Information Technology risk.

Printable version